Hi-Tech Pharma Enters Oversold Territory - Tale of the Tape

By Zacks.com,  December 12, 2011, 10:35:01 AM EDT

Hi-Tech Pharmacal Co. 's ( HITK ) share price has entered into oversold territory with a stochastic value of 16.140. The Zacks Consensus Estimate on the company's earnings for April 2012 increased by 29 cents over the past week to $3.61 per share. Hi-Tech Pharmacal Co. is a Zacks #1 Rank ("Strong Buy") company.


 
HI TECH PHARMA ( HITK ): Free Stock Analysis Report
 
Zacks Investment Research




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.


This article appears in: Investing, Investing Ideas, Stocks

Referenced Stocks: HITK



Latest News Video

Fire Destroys Rio Fuel Depot
Fire Destroys Rio Fuel Depot        
Housing's Healing Gains Pace
Housing's Healing Gains Pace        
What Sectors Are Vulnerable Now?
What Sectors Are Vulnerable Now?    
From Google to FedEx: Less Offshore Holdings? Maybe Not
From Google to FedEx: Less Offshore...


Sign-in
Existing NASDAQ.com member? Log in here.

By signing into to the site using any of the third-party services above, you agree to NASDAQ.com's Terms of Use.

From Our Trusted News Source





Most Active by Volume:

Company Last Sale Change Net / %
BAC $ 13.21 0.10  0.75%
HPQ $ 24.86 3.63  17.10%
SIRI $ 3.545 0.01  0.28%
MU $ 11.39 0.47  4.30%
MSFT $ 34.15 0.46  1.33%
F $ 14.81 0.16  1.07%
QQQ $ 73.45 0.17  0.23%
GE $ 23.66 0.20  0.84%